| abstract |
The present invention is 3- (2,6-dichloro-3,5-dimethoxy-phenyl) -1- {6- [4- (4-ethyl-piperazin-1-yl) -phenylamino] -pyrimidine- Novel anhydrous and hydrated crystalline forms of 4-yl} -1-methyl-urea, amorphous and anhydrous crystalline polymorphs of monophosphate salts thereof, and hydrochloride salts thereof are provided. The present invention further provides various forms of methods of preparation, compositions containing them, and methods of treatment using them. |